These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 11157652)
1. Antithrombotic agents in coronary artery disease. Cairns JA; Théroux P; Lewis HD; Ezekowitz M; Meade TW Chest; 2001 Jan; 119(1 Suppl):228S-252S. PubMed ID: 11157652 [No Abstract] [Full Text] [Related]
2. [Prevention of embolism in atrial septal defects?]. Franke A Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S13-4. PubMed ID: 10818999 [No Abstract] [Full Text] [Related]
3. Thromboprophylaxis--which treatment for which patient? Thomas DP J Bone Joint Surg Br; 2000 Sep; 82(7):1083-4. PubMed ID: 11041607 [No Abstract] [Full Text] [Related]
4. A perspective on the potential problems with aspirin as an antithrombotic agent: a comparison of studies in an animal model with clinical trials. Folts JD; Schafer AI; Loscalzo J; Willerson JT; Muller JE J Am Coll Cardiol; 1999 Feb; 33(2):295-303. PubMed ID: 9973006 [TBL] [Abstract][Full Text] [Related]
5. Antithrombotic agents in coronary artery disease. Cairns JA; Lewis HD; Meade TW; Sutton GC; Théroux P Chest; 1995 Oct; 108(4 Suppl):380S-400S. PubMed ID: 7555191 [No Abstract] [Full Text] [Related]
6. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease. Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510 [TBL] [Abstract][Full Text] [Related]
8. Can aspirin ever be surpassed for stroke prevention? Tong DC Stroke; 2003 Apr; 34(4):847-8. PubMed ID: 12680382 [No Abstract] [Full Text] [Related]
9. Antithrombotic therapy in patients with heart valve prostheses. Hermans H; Vanassche T; Herijgers P; Meuris B; Herregods MC; Van de Werf F; Verhamme P Cardiol Rev; 2013; 21(1):27-36. PubMed ID: 22695380 [TBL] [Abstract][Full Text] [Related]
10. Unstable coronary artery disease: need for long-term antithrombotic treatment? Aspirin alone may not be the ideal antithrombotic strategy, but that's what we have adequate trial data for. Patrono C Cardiovasc Res; 1997 Feb; 33(2):295-6. PubMed ID: 9074692 [No Abstract] [Full Text] [Related]
11. New antithrombotic drugs for systemic and local delivery for coronary artery disease. Shah PK J Interv Cardiol; 1995 Aug; 8(4):427-37. PubMed ID: 10155257 [No Abstract] [Full Text] [Related]
12. Mapping out the future in venous thromboembolism and acute coronary syndromes. Heit JA Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():33-9. PubMed ID: 12232821 [TBL] [Abstract][Full Text] [Related]
16. Antithrombotics in atrial fibrillation and coronary disease. Velagapudi P; Turagam MK; Agrawal H; Mittal M; Kocheril AG; Aggarwal K Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):977-86. PubMed ID: 25046150 [TBL] [Abstract][Full Text] [Related]
17. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease. Thompson PL; Verheugt FW Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549 [TBL] [Abstract][Full Text] [Related]
18. Antithrombotic treatment in atrial fibrillation. Lip GY; Boos CJ Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982 [TBL] [Abstract][Full Text] [Related]
19. [Clopidogrel should be added to aspirin for at least 1 year after percutaneous coronary interventions (CREDO) while before them its loading dose can reach 600mg (ISAR-COOL)]. Gratsianskiĭ NA Kardiologiia; 2003; 43(5):71-3. PubMed ID: 12942928 [No Abstract] [Full Text] [Related]
20. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]